Skip to main content
Log in

Chronic Administration of Oren-gedoku-to (TJ15) Inhibits Ischemia-Induced Changes in Brain Indoleamine Metabolism and Muscarinic Receptor Binding in the Mongolian Gerbil

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

We examined the effect of Oren-gedoku-to (TJ15), which is a traditional herbal Kampo prescription used as an anti-cerebral apoplexy agent on these changes. Chronic pre- and post-ischemia TJ15 oral administration almost completely abolished the ischemia-induced muscarinic receptor reduction and 5-hydroxyindoleacetic acid level increase. These results suggest that TJ15 prevents cholinergic synaptic dysfunction and serotonergic presynaptic hyperactivity induced by transient ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Klisch, J., and Bode Greuel, K. M. 1992. Ketanserin reduces neuronal calcium accumulation and cell death in the hippocampus of the Mongolian gerbil after transient forebrain ischemia. Brain Res. 578:1–7.

    Google Scholar 

  2. Frolich, L., Dirr, A., Riederer, P., and Hoyer, S. 1993. Effects of long-term recovery from transient cerebral ischemia in rat brain: tissue levels of acetylcholine, monoamines, and their metabolites. Neurochem. Res. 18:1239–1244.

    Google Scholar 

  3. Araki, T., Kato, H., and Kogure, K. 1992. Postischemic alteration of muscarinic acetylcholine and adenosine A1 binding sites in gerbil brain. Protective effects of a novel vinca alkaloid derivative, vinconate, and pentobarbital using an autoradiographic study. Res. Exp. Med. Berl. 192:79–88.

    Google Scholar 

  4. Katsura, M., Iino, T., and Kuriyama, K. 1992. Changes in content of neuroactive amino acids and acetylcholine in the rat hippocampus following transient forebrain ischemia. Neurochem. Int. 21:243–249.

    Google Scholar 

  5. Ogawa, N., Asanuma, M., Mizukawa, K., Hirata, H., Chou, H., and Mori, A. 1992. Post-ischemic administration of bifemelane hydrochloride prohibits ischemia-induced depletion of the muscarinic M1-receptor and its mRNA in the gerbil hippocampus. Brain Res. 591:171–175.

    Google Scholar 

  6. Ogawa, N., Tanaka, K., Kondo, Y., Asanuma, M., Mizukawa, K., and Mori, A. 1993. The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia. Neurosci. Lett. 152:173–176.

    Google Scholar 

  7. Kondo, Y., Ogawa, N., Asanuma, M., Nishibayashi, S., Iwata, E., and Mori, A. 1995. Cyclosporin A prevents ischemia-induced reduction of muscarinic acetylcholine receptors with suppression of microglial activation in gerbil hippocampus. Neurosci. Res. 22:123–127.

    Google Scholar 

  8. Haba, K., Ogawa, N., and Mori, A. 1990. The effect of Sho-saiko-to-go-keishi-ka-shakuyaku-to (TJ-960) on ischemia-induced changes of brain acetylcholine and monoamine levels in gerbils. Neurochem. Res. 15:487–493.

    Google Scholar 

  9. Haba, K., Ogawa, N., Asanuma, M., Hirata, H., and Mori, A. 1992. Comparison of the effects of bifemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischemia-induced changes in brain monoamines and their metabolites in gerbils. J. Neural Transm. 88:187–198.

    Google Scholar 

  10. Hasegawa, T. 1984. Clinical effect of Oren-gedoku-to on cerebrovascular disorders. In: Oda T et al, eds. Recent advances in traditional medicine in East Asia, ICS693. Tokyo: Excepta Medica. 209–218.

    Google Scholar 

  11. Ozaki, M., Ohta, H., and Sekine, I. 1985. Effect of Choto-san and Oren-gedoku-to on blood pressure in rat (SHR-SP) susceptible to cerebral apoplexy. J. Med. Pharm. Soc. Wakan-Yaku. 2:560–561. (In Japanese).

    Google Scholar 

  12. Kuwaki, T. 1979. Effects of Oren-gedoku-to and other Kampo prescriptions in cases of hypertension. Nihon Tokyo Igakkaisi. 29:105–113.

    Google Scholar 

  13. Glowinski, J., and Iversen, L. L. 1966. Regional studies of catecholamines in the rat brain. J. Neurochem., 13:655–669.

    Google Scholar 

  14. Kabuto, H., Yokoi, I., Mori, A., Murakami, M., and Sawada, S. 1995. Neurochemical changes related to aging in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine. Mech. Ageing Dev. 80:1–9.

    Google Scholar 

  15. Kabuto, H., Yokoi, I., and Mori, A. 1992. Monoamine metabolites, iron induced seizures, and the anticonvulsant effect of tannins. Neurochem. Res. 17:585–590.

    Google Scholar 

  16. Fujimori, K., and Yamamoto, K. 1987. Determination of acetylcholine in perchlorale extracts of brain tissue using liquid chromatography-electrochemistry with an immobilized-enzyme reactor. J. Chromotogr., 414:167–173.

    Google Scholar 

  17. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275.

    Google Scholar 

  18. Ogawa, N., Mizuno, S., Nukina, I., Tsukamoto, S., and Mori, A. 1983. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS. Brain Res. 263:348–350.

    Google Scholar 

  19. Deutch, J. A., Hamburg, M. D., and Dahl, H. 1966. Anti-choline esterase-induced amnesia and its temporal aspects, Science, 151:221–223.

    Google Scholar 

  20. Gibson, G. E., and Duffy, T. E. 1981. Impaired synthesis of acetylcholine by mild hypoxic hypoxia or nitrous oxide. J. Neurochem. 36:28–33.

    Google Scholar 

  21. Gibson, G. E., Shimada, M., and Biass, J. P. 1978. Alterations in acetylcholine synthesis and cyclic nucleotides in mild cerebral hypoxia. J. Neurochem. 31:757–760.

    Google Scholar 

  22. Hammer, R., and Giachetti, A. 1984. Selective muscarinic receptor antagonists, Trends Pharmacol. Sci., 5:18–20.

    Google Scholar 

  23. Lin, S. C., Olson, K. C., Okazaki, H., and Richelson, E. 1986. Studies on muscarinic binding sites in human brain identified with [3H]pirenzepine. J. Neurochem. 46:274–279.

    Google Scholar 

  24. Mash, D. C., Flynn, D. D., and Rotter, L. T. 1985. Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation, Science. 228:1115–1117.

    Google Scholar 

  25. Haba, K., Ogawa, N., Mizukawa, K., and Mori, A. 1991. Time course of changes in lipid peroxidation, pre-and postsynaptic cholinergic indices, NMDA receptor binding and neuronal death in the gerbil hippocampus following transient ischemia. Brain Res. 540:116–122.

    Google Scholar 

  26. Nagasawa, H., and Kogure, K. 1988. Efficacy of Oren-gedoku-to (TJ15) in a model of chronic cerebral ischemia. In: Hosoya, E. and Yamamura, Y. eds. Recent advances in Pharmacology of Kampo (Japanese herbal) medicines. Tokyo: Excepta Medica. 213–218.

    Google Scholar 

  27. Fushitani, S., Tsuchiya, K., Minakuchi, K., Takasugi, M., and Murakami, K. 1994. Studies on attenuation of post-ischemic brain injury by kampo medicines-inhibitory effects of free radical production. I. Yakugaku-Zasshi. 114:388–394. in Japanese.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kabuto, H., Asanuma, M., Nishibayashi, S. et al. Chronic Administration of Oren-gedoku-to (TJ15) Inhibits Ischemia-Induced Changes in Brain Indoleamine Metabolism and Muscarinic Receptor Binding in the Mongolian Gerbil. Neurochem Res 22, 33–36 (1997). https://doi.org/10.1023/A:1027369119224

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1027369119224

Navigation